The Limitations of Cytomegalovirus DNA Detection in Cerebrospinal Fluid of Newborn Infants With Congenital CMV Infection: A Tertiary Care Neonatal Center Experience
| Autor: | Dariusz Gruszfeld, Eliza Sarkaria, Anna Dobrzańska, Dorota Dunin-Wąsowicz, Beata Kasztelewicz, Anna Niezgoda, Kinga Gradowska, Dominika Jedlińska-Pijanowska, Magdalena Kłodzińska, Aleksandra Pietrzyk, Justyna Czech-Kowalska |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male Microbiology (medical) medicine.medical_specialty Microcephaly Congenital cytomegalovirus infection Cytomegalovirus Mothers Polymerase Chain Reaction Gastroenterology Cohort Studies Neonatal Screening Cerebrospinal fluid Internal medicine medicine Humans Hepatitis Tertiary Healthcare business.industry Infant Newborn Brain Odds ratio medicine.disease Magnetic Resonance Imaging Confidence interval Logistic Models Infectious Diseases Cytomegalovirus Infections DNA Viral Pediatrics Perinatology and Child Health Female Sensorineural hearing loss business Biomarkers Ventriculomegaly |
| Zdroj: | Pediatric Infectious Disease Journal. 40:838-845 |
| ISSN: | 0891-3668 |
| DOI: | 10.1097/inf.0000000000003205 |
| Popis: | Background Congenital cytomegalovirus (cCMV) infection of the central nervous system (CNS) can cause ventriculomegaly, gliosis, calcifications and cortical defects. Detection of CMV DNA in cerebrospinal fluid by PCR (CSF-CMV-PCR) is a marker of CNS involvement. Objective To evaluate a diagnostic value of the positive CSF-CMV-PCR in cCMV. Methods Analysis of clinical, laboratory, neuroimaging and single-nucleotide polymorphisms (SNPs) data according to the results of CSF-CMV-PCR were performed in infants with cCMV. Results A total of 168 infants were included; 145 (86.3%) had negative and 23 (13.7%) had positive CSF-CMV-PCR results. Associations between the positive CSF-CMV-PCR results and prematurity (odds ratio [OR] = 3.24; 95% confidence interval [CI]: 1.30-8.07), microcephaly (OR = 5.67; 95% CI: 2.08-15.41), seizures (OR = 4.15; 95% CI: 1.10-15.67), sensorineural hearing loss (OR = 6.6; 95% CI: 2.49-17.46), splenomegaly (OR = 8.13; 95% CI: 3.12-21.16), hepatitis (OR = 10.51; 95% CI: 3.31-33.35), petechiae (OR = 10.21; 95% CI: 3.78-27.57) and heterozygous T/C genotype at TLR4rs4986791 (OR = 7.88; 95% CI: 1.55-40.12) were observed. When using a multivariate logistic regression analysis, only the presence of severe sensorineural hearing loss (OR = 7.18; 95% CI: 1.75-29.34, P = 0.006), cystic lesions on MRI (OR 5.29; 95% CI: 1.31-21.36, P = 0.02), and calcifications on MRI (OR = 7.19; 95% CI: 1.67-30.97, P = 0.008) remained as the significant independent predictors of the positive CSF-CMV-PCR results. Conclusions The detection of CMV DNA in CSF is associated with a higher rate of CNS damage including abnormal MRI neuroimaging and severe hearing loss. Therefore, detection of CMV DNA in CSF may be considered as a marker of severe CNS injury in cCMV infection. However, the very low prevalence of the positive CSF-CMV-PCR results, even in infants with proven CNS involvement, may imply its limited role in clinical practice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|